US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

44.35

-0.2723-0.61%

Post-market: 44.350.00000.00%16:10 EDT

Volume:3K

Turnover:116.71K

Market Cap:5.54M

PE:- -

High:44.71

Open:44.71

Low:44.35

Close:44.62

52wk High:45.10

52wk Low:25.71

Shares:125.00K

Float Shares:125.00K

Volume Ratio:0.65

T/O Rate:2.10%

Dividend:0.62

Dividend Rate:1.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sino Biopharmaceutical Stock Falls 2.0% in Hong Kong, Underperforms Competitors

Amgen SVP Business Development Rachna Khosla Sells Common Shares Worth $1.67 Million

Assembly Bio Releases Corporate Deck Highlighting Clinical-Stage Pipeline, Gilead-Partnered HSV Program

Assembly Biosciences Q2 Net Loss Narrows as Revenue Rises

Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Argenx Advances Empasiprubart in Rare Nerve Disorder, Adding Long-Term Upside for ARGX Investors

Your Prescription Drugs Shouldn't Cost More than Your Mortgage. Inside the Broken Math That Got US Here.

Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks

Moderna Inc. Stock Rises 5.1%, Outperforms Peers

Regeneron Director Huda Y. Zoghbi Disposes of USD 640,000 in Common Shares

Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)

Vertex 1Q Net Y772.00m vs Net Y658.00m

Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors

Amgen to Open New Science & Innovation Center in Genome Valley, Hyderabad

THOMSON REUTERS

MacroGenics Rises on $10 Million Milestone Payment from Gilead

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

MacroGenics Raih Pembayaran USD 10 Juta Usai Gilead Ambil Lisensi Program Bispesifik Praklinis

MacroGenics - Remains Eligible to Receive up to Approximately $1.6 Bln in Additional Development

THOMSON REUTERS

Amgen’s AMG 355 Trial Completion: What This Early Cancer Study Means for AMGN Investors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/TBXU/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":44.3509,"timestamp":1787774400000,"preClose":44.6232,"halted":0,"volume":2619,"hourTrading":{"tag":"盘后","latestPrice":44.3509,"preClose":44.3509,"latestTime":"16:10 EDT","volume":7,"amount":310.4563,"timestamp":1787775005093,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.006102206923752538,"floatShares":125000,"shares":125000,"eps":0,"marketStatus":"Post-Mkt","change":-0.2723,"latestTime":"08-26 16:44:26 EDT","open":44.71,"high":44.71,"low":44.35,"amount":116714,"amplitude":0.008068,"askPrice":50.56,"askSize":10,"bidPrice":37.5,"bidSize":30,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787788800000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":44.6232,"sharesOutstanding":100001,"nav":44.014,"aum":5501832.71,"dividendRate":0.01402,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":44.3509,"preClose":44.3509,"latestTime":"16:10 EDT","volume":7,"amount":310.4563,"timestamp":1787775005093,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.651655},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":125000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.651655,"shares":125000,"dividePrice":0.6218,"high":44.71,"amplitude":0.008068,"preClose":44.6232,"low":44.35,"week52Low":25.71,"pbRate":"--","week52High":45.1,"institutionHeld":0,"latestPrice":44.3509,"committee":0.5,"eps":0,"divideRate":0.01402,"volume":2619,"delay":0,"ttmEps":0,"open":44.71,"prevYearClose":31.065,"prevWeekClose":44.4163,"prevMonthClose":34.3127,"prevQuarterClose":32.1223,"fiveDayClose":44.7799,"twentyDayClose":33.7939,"sixtyDayClose":27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659011101","title":"Sino Biopharmaceutical Stock Falls 2.0% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2659011101","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659011101?lang=en_us&edition=fundamental","pubTime":"2026-08-14 16:31","pubTimestamp":1786696260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 2.0% to 4.78 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.1% to 25116.85.This was the stock's fifth consecutive day of losses.Sino Biopharmaceutical Ltd. closed 48% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 1.8% and Amgen Inc. remained unchanged.Trading volume totaled 45.4 million shares, compared to the 50-day average of 98.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","HK0000165453.HKD","LU0320765992.SGD","BK4534","LU1023059063.AUD","BK1589","IE00BZ08YR35.GBP","LU0058720904.USD","LU0122379950.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IBBQ","BK4599","LU2468319806.SGD","PJP","BK4585","IE00BZ08YT58.USD","BK1521","BK4588","IE0009355771.USD","LU0289739699.SGD","LU1057294990.SGD","LU0889565916.HKD","SG9999001440.SGD","BK4533","LU2242652126.USD","AMGN","LU2242646821.SGD","IE00BJJMRZ35.SGD","BK1515","PBE","BK1191","LU2089984988.USD","01177","TBXU","LU1061106388.HKD","BBH","IE00BZ08YS42.EUR","BK4139","BK4581","IBB","IE00BJT1NW94.SGD","LU0868494617.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1571399168.USD","BIB","LU0109394709.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659195519","title":"Amgen SVP Business Development Rachna Khosla Sells Common Shares Worth $1.67 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659195519","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659195519?lang=en_us&edition=fundamental","pubTime":"2026-08-14 07:06","pubTimestamp":1786662376,"startTime":"0","endTime":"0","summary":"Amgen SVP Business Development Rachna Khosla sells common shares worth $1.67 millionAmgen SVP, Business Development Rachna Khosla sold 2,000 common shares on Aug. 11 at USD 412.57.She exercised 1,252 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL19HYFD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Amgen SVP Business Development Rachna Khosla Sells Common Shares Worth $1.67 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IBBQ","LU1023059063.AUD","LU0320765992.SGD","BK4533","BK4566","IE0002141913.USD","TBXU","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU2242652126.USD","LU2468319806.SGD","LU1571399168.USD","LU2242646821.SGD","BK4534","BIB","BK4599","LU1061106388.HKD","PBE","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4588","IE00B4R5TH58.HKD","BK4585","LU2089984988.USD","LU1057294990.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2112291526.USD","LU0122379950.USD","LU1983299246.USD","SG9999001440.SGD","AMGN","IBB","BK4139","LU0868494617.USD","LU0109394709.USD","PJP","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167794","title":"Assembly Bio Releases Corporate Deck Highlighting Clinical-Stage Pipeline, Gilead-Partnered HSV Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167794","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167794?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:36","pubTimestamp":1786653366,"startTime":"0","endTime":"0","summary":"Assembly Bio releases corporate deck highlighting clinical-stage pipeline, Gilead-partnered HSV programAssembly Biosciences outlined three Phase 2 starts across its portfolio in late 2026 to early 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL90nFdX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU2089984988.USD","LU2468319806.SGD","LU0320765992.SGD","LU0114720955.EUR","LU1023059063.AUD","TBXU","LU1057294990.SGD","ASMB","IE00B19Z3581.USD","IBB","SG9999015986.USD","SG9999015945.SGD","LU2112291526.USD","BK4566","LU1674673428.USD","BK4532","LU0109394709.USD","LU0234570918.USD","LU1934455194.USD","LU1934455863.HKD","LU1066051498.USD","IE00B3T34201.USD","BK4568","GILD","LU0122379950.USD","BK4585","IBBQ","LU2324357040.USD","BK4588","LU2087621335.USD","LU1585245621.USD","BK4578","BMED","BBH","LU0823416689.USD","LU0889565916.HKD","MEDI","LU0882574055.USD","LU1839511570.USD","LU0289739699.SGD","LU1066053197.SGD","LU1571399168.USD","SG9999015952.SGD","TMED","LU0965509101.SGD","BK4139","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162459","title":"Assembly Biosciences Q2 Net Loss Narrows as Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162459","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162459?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:09","pubTimestamp":1786651778,"startTime":"0","endTime":"0","summary":"Assembly Biosciences Q2 net loss narrows as revenue risesOverviewUS biotech firm's Q2 revenue from Gilead collaboration rose yr/yr, net loss narrowedLower net loss driven by higher revenue, reduced R&","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A13Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU0109394709.USD","LU1934455277.USD","GILD","LU0882574055.USD","LU0122379950.USD","LU1023059063.AUD","LU1066053197.SGD","BK4007","BK4139","LU1674673691.USD","LU0965509010.AUD","BK4566","LU0114720955.EUR","IE00B7SZLL34.SGD","LU2087621335.USD","ARTL","LU1571399168.USD","LU2468319806.SGD","IE00BZ1G4Q59.USD","MEDI","TBXU","LU1061106388.HKD","BK4505","LU0889565916.HKD","LU0965508806.USD","LU0965509283.SGD","LU1934455194.USD","LU1839511570.USD","LU0289739699.SGD","IBBQ","IBB","LU0320765992.SGD","LU1674673428.USD","BK4568","SG9999015978.USD","AVIR","LU1057294990.SGD","LU2112291526.USD","SG9999015986.USD","TMED","IE00B3T34201.USD","IE00B19Z3581.USD","ASMB","NKTX","BBH","LU1585245621.USD","BK4588","BK4578","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162947","title":"Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162947","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162947?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"clinical trial were presented at the 2026 European Hematology Association.  Annual Meeting. Data presented reinforced vispa-cel is the only. single-dose, off-the-shelf therapy to demonstrate deep and durable. responses on par with autologous CAR-T cell therapies in second-line . large B cell lymphoma . Efficacy and safety data in 2L LBCL. patients who had received a single dose of 80 million optimized vispa-cel. -- Optimized vispa-cel is defined as cells from a donor younger than 30. years old with at least two matched human leukocyte antigen  alleles. between patient and donor. The 27-patient subgroup best represents the. treatment regimen and patient population for Caribou's planned ANTLER-3. -- Caribou previously reached alignment with the U.S. Food and Drug. Administration  regarding its planned ANTLER-3 pivotal phase 3. clinical trial design, which is expected to be a randomized, control","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORR","MEDX","NVIB","CAR","GNOM","IBB","IDNA","BK4195","BK4211","CR","IBBQ","BK4161","PFS","BK4022","GDOC","TBXU","BK4230","BK4139","CNCR","BK4585","FBT","SYNB","LFSC","BK4588","CRBU","BK4539","HYLG","LD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659093166","title":"Argenx Advances Empasiprubart in Rare Nerve Disorder, Adding Long-Term Upside for ARGX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2659093166","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659093166?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:31","pubTimestamp":1786638686,"startTime":"0","endTime":"0","summary":"Argenx ($ARGX) announced an update on their ongoing clinical study. The new argenx study focuses on empasiprubart in adults with multifocal motor n...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/argenx-advances-empasiprubart-in-rare-nerve-disorder-adding-long-term-upside-for-argx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/argenx-advances-empasiprubart-in-rare-nerve-disorder-adding-long-term-upside-for-argx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1983260115.SGD","IE0009355771.USD","LU0889565916.HKD","BK4505","ISBC","FMED","BK4588","BK4211","IE00BFTCPJ56.SGD","LU0109394709.USD","IE00BJT1NW94.SGD","LU0823416689.USD","IBB","LU0320765992.SGD","IE00B2B36J28.USD","TBXU","IE0034235188.USD","ARGX","BK4139","IE0002141913.USD","LU2324357040.USD","BK4585","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165887","title":"Your Prescription Drugs Shouldn't Cost More than Your Mortgage. Inside the Broken Math That Got US Here.","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165887","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165887?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:02","pubTimestamp":1786633320,"startTime":"0","endTime":"0","summary":"Here's how I would fix drug pricesThe same system that motivates companies to seek out innovative therapies may also engender bad behavior.For many Americans, the price of prescription drugs is an eni","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IBBQ","IE00BSNM7G36.USD","SG9999015952.SGD","IE0002270589.USD","TBXU","BK4566","LU2087621335.USD","LU0823416689.USD","LU1585245621.USD","LU0109394709.USD","LU0965509283.SGD","LU1023059063.AUD","IE00BKVL7J92.USD","LU0965509010.AUD","IE00B7SZLL34.SGD","SG9999015945.SGD","GILD","SG9999015986.USD","BBH","MEDI","BK4568","IE00B19Z3B42.SGD","BK4585","BK4139","BK4550","LU2089984988.USD","LU1057294990.SGD","LU0289739699.SGD","BK4578","LU0320765992.SGD","LU1066051498.USD","LU2468319806.SGD","BK4532","LU0114720955.EUR","LU2324357040.USD","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU0058720904.USD","BMED","IBB","BK4588","LU1839511570.USD","LU0234570918.USD","LU1571399168.USD","LU1430594728.SGD","LU1778281490.HKD","SG9999015978.USD","LU1061106388.HKD","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659926188","title":"Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659926188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659926188?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:37","pubTimestamp":1786567029,"startTime":"0","endTime":"0","summary":"The latest update is out from Outlook Therapeutics ( ($OTLK) ). On July 24, 2026, Outlook Therapeutics announced U.S. FDA approval of LYTENAVA (bev...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/outlook-therapeutics-ends-atm-prospectus-amid-ongoing-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/outlook-therapeutics-ends-atm-prospectus-amid-ongoing-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","PINK","BK4007","IYH","LABU","RSPH","IDNA","PSCH","GDOC","TBXU","XLVX","NVIB","MEDI","BK4585","SYNB","TECB","MRNX","BK4139","FRTY","BK4539","IEIH","BBP","GNMX","BK4588","IBB","BMED","MRNY","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188699","title":"Moderna Inc. Stock Rises 5.1%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188699","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188699?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:34","pubTimestamp":1786566840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rallied 5.1% to $63.67 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.5% to 26,588.49 and the Dow Jones Industrial Average remaining mostly unchanged at 53,770.27.This was the stock's fourth consecutive day of gains.Moderna Inc. closed 25.6% below its 52-week high of $85.60, which the company reached on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.4% to $260.86, Pfizer Inc. fell 1.2% to $26.31, and Gilead Sciences Inc. rose 0.07% to $135.87.Trading volume totaled 6.0 million, compared to the 50-day average of 7.3 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","MRNA","MRNX","LU1674673691.USD","LU1934455194.USD","LU2087621335.USD","MEDI","IE00BKVL7J92.USD","LU1585245621.USD","LU2112291526.USD","BK4532","IDNA","BK4588","LU1430594728.SGD","BK4501","LU1037948541.HKD","BK4550","BBH","LU0823416689.USD","TMED","LU1057294990.SGD","IE00B19Z3581.USD","IE0002270589.USD","IE00BSNM7G36.USD","LU0889565916.HKD","BMED","GNOM","LU2324357040.USD","WDNA","LU1037948897.HKD","LU1023059063.AUD","SG9999015978.USD","LU1674673428.USD","BK4139","BIB","TBXU","LGHT","GILD","LU0882574055.USD","LU1061106388.HKD","LU0965508806.USD","BK4551","LU0289739699.SGD","BK4566","IBB","BK4585","MRNY","LU1066051498.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900645","title":"Regeneron Director Huda Y. Zoghbi Disposes of USD 640,000 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900645","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900645?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:15","pubTimestamp":1786565759,"startTime":"0","endTime":"0","summary":"Regeneron director Huda Y. Zoghbi disposes of USD 640,000 in common sharesRegeneron director Huda Y. Zoghbi sold 800 shares on Aug. 10 at USD 800 per share.She exercised 800 non-qualified stock option","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLcgcpl4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Regeneron Director Huda Y. Zoghbi Disposes of USD 640,000 in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541273.HKD","LU0889565916.HKD","IBB","BK4588","LU0320765992.SGD","LU0114720955.EUR","LU1974910355.USD","LU2362541513.USD","LU2106854487.HKD","BK4139","LU0289739699.SGD","LU1917777945.USD","LU0823434583.USD","LU0058720904.USD","REGN","IBBQ","LU2023250504.SGD","BK4585","LU0823434740.USD","LU2362540622.SGD","TBXU","LU0882574055.USD","LU0053666078.USD","LU0109394709.USD","LU0823416689.USD","BBH","LU2237438978.USD","LU2468319806.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658290503","title":"Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658290503","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658290503?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:02","pubTimestamp":1786546971,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  has multiple potential catalysts coming from its portfolio that provide a net positive risk-reward profile for the company, RBC Capital Markets said in a Wednesday note.The company is expected to present results from its phase 1 study of VX-828 in patients with cystic fibrosis in H2, with a positive readout potentially strengthening its competitive advantage in the space, RBC analysts said.Favorable data will likely result in modest upside, while unfavorable data will likely lead to little downside, the analysts added.Meanwhile, approval by the US Food and Drug Administration for Vertex's povetacicept in immunoglobulin A nephropathy, with a PDUFA date of Nov. 30, 2026, is likely due to strong interim phase 3 results, the analysts said.They said that the drug's differentiated profile could make it the preferred choice of most doctors.With Sionna Therapeutics  failing to demonstrate significant sweat chloride improvements as an add-on to Trikafta, one of the more ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0058720904.USD","VRTX","BK4585","SGXZ57979304.SGD","LU0566484027.USD","BBH","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","BIB","SION","IDNA","LU0061475181.USD","BK4023","LU0109394709.USD","BK4532","LU1815336091.USD","TBXU","BK4139","LU0417517546.SGD","IE00BJJMRZ35.SGD","LU1674673691.USD","IBBQ","LU2417539215.USD","IE00B19Z3581.USD","IE00B19Z9Z06.USD","LU2237438978.USD","LU2324357040.USD","PBE","IE00B2B36J28.USD","LU2362541273.HKD","SG9999013999.USD","LU1069344957.HKD","GNMX","BK4567","IBB","IE00BZ9MQY76.HKD","LU2362540622.SGD","LU2456880835.USD","IE00BFTCPJ56.SGD","LU1559883803.SGD","LU1430594728.SGD","LU2362541513.USD","LU1093756325.SGD","VERX","LU1778281490.HKD","LU0079474960.USD","BK4588","BK4533","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974863","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974863?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:10","pubTimestamp":1786533037,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Brookdale Senior Livi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-brookdale-senior-living-bkd-and-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-brookdale-senior-living-bkd-and-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1499592464.USD","LU0234570918.USD","IE0002270589.USD","LU1778281490.HKD","LU2468319806.SGD","SG9999001176.USD","BK4532","LU0079474960.USD","GNMX","TBXU","LU0417517546.SGD","LU0058720904.USD","LU0061475181.USD","HCSG","LU1815336091.USD","LU0757428866.USD","LU2417539215.USD","IE00B894F039.SGD","LU0029874061.USD","BIB","IE00B19Z3581.USD","BK4505","XLV","XBI","IE00BZ9MQY76.HKD","LU1430594728.SGD","LU2237438978.USD","LU0432979614.USD","BKD","BBH","PBE","IBBQ","LU1035775433.USD","BK4185","LU2089984988.USD","IE00B19Z3B42.SGD","BK4588","LU2462157665.USD","MEMS","LU1674673691.USD","MEDI","LU1585245621.USD","SG9999001176.SGD","VERX","VRTX","CANC","IBB","IDNA","LEGN","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658414920","title":"Vertex 1Q Net Y772.00m vs Net Y658.00m","url":"https://stock-news.laohu8.com/highlight/detail?id=2658414920","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658414920?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:41","pubTimestamp":1786524060,"startTime":"0","endTime":"0","summary":"Results are based on Japanese accounting standards.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE0009355771.USD","LU0432979614.USD","BIB","GNMX","LU0079474960.USD","LU1778281490.HKD","IDNA","IBB","SG9999013999.USD","LU0058720904.USD","LU0823416689.USD","LU1430594728.SGD","LU1674673428.USD","SGXZ57979304.SGD","LU1815336091.USD","VERX","LU0757428866.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","BK4023","IE00B4R5TH58.HKD","IE00B894F039.SGD","LU1674673691.USD","LU0234570918.USD","BBH","LU1035775433.USD","SG9999001176.USD","VRTX","LU2362541513.USD","LU0566484027.USD","BK4585","IE0002141913.USD","BK4588","LU1093756325.SGD","LU2456880835.USD","SG9999001176.SGD","LU2237438978.USD","LU0289739699.SGD","TBXU","PBE","LU2462157665.USD","LU0256863811.USD","IE00BZ9MQY76.HKD","BK4567","IE00B19Z9P08.USD","IBBQ","LU2089984988.USD","LU2468319806.SGD","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658920953","title":"Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658920953","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658920953?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:33","pubTimestamp":1786523580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 1.5% to 4.93 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.8% to 25440.17.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 46% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.3% and Amgen Inc. remained unchanged.Trading volume totaled 51.4 million shares, compared to the 50-day average of 99.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","IE00B2B36J28.USD","BK4599","LU0289739699.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2468319806.SGD","BK4566","BK1191","IE00BZ08YT58.USD","AMGN","LU0320765992.SGD","LU0109394709.USD","LU2242646821.SGD","BK4581","IBB","IE00BZ08YR35.GBP","BK4585","TBXU","01177","IE00BJJMRZ35.SGD","BK4139","SG9999001440.SGD","IE00BZ08YS42.EUR","LU1061106388.HKD","BK4588","HK0000165453.HKD","LU0058720904.USD","LU0868494617.USD","LU2112291526.USD","PBE","LU2242652126.USD","PJP","LU1571399168.USD","IE0002141913.USD","BK1521","BK4533","BK1515","BBH","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1983299246.USD","LU2089984988.USD","LU0889565916.HKD","BIB","IE00B4R5TH58.HKD","IBBQ","LU1057294990.SGD","LU0122379950.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658277549","title":"Amgen to Open New Science & Innovation Center in Genome Valley, Hyderabad","url":"https://stock-news.laohu8.com/highlight/detail?id=2658277549","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658277549?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:26","pubTimestamp":1786523176,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490HP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMGN","LU0889565916.HKD","IE0009355771.USD","BK4599","LU0109394709.USD","BIB","LU2242646821.SGD","IBB","SG9999001440.SGD","BK4139","LU1983299246.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU1061106388.HKD","BK4566","BK4581","BK4533","LU0320765992.SGD","IBBQ","IE00B2B36J28.USD","BK4585","BK4588","LU0289739699.SGD","LU2468319806.SGD","BK4534","LU0868494617.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU0122379950.USD","PBE","LU0058720904.USD","BBH","LU1571399168.USD","PJP","TBXU","LU2112291526.USD","IE00BJT1NW94.SGD","LU2089984988.USD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658946551","title":"MacroGenics Rises on $10 Million Milestone Payment from Gilead","url":"https://stock-news.laohu8.com/highlight/detail?id=2658946551","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658946551?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:17","pubTimestamp":1786483066,"startTime":"0","endTime":"0","summary":"BUZZ-MacroGenics rises on $10 million milestone payment from Gilead** Shares of drug developer MacroGenicsMGNX.Orise 3.8% to $4.07 in extended trading** Company says it has received a $10 million mile","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N4481HW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU1571399168.USD","LU1674673691.USD","LU0965509010.AUD","LU1934455194.USD","LU2087621335.USD","MEDI","LU0965509101.SGD","LU1585245621.USD","LU2112291526.USD","BK4532","BK4588","LU1430594728.SGD","LU1037948541.HKD","LU2089984988.USD","BK4550","BBH","LU0823416689.USD","LU0965509283.SGD","LU0109394709.USD","TMED","SG9999015952.SGD","LU1057294990.SGD","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU0889565916.HKD","BMED","LU2468319806.SGD","SG9999015945.SGD","LU1934455863.HKD","LU2324357040.USD","LU1037948897.HKD","LU1023059063.AUD","LU0114720955.EUR","BIB","TBXU","GILD","IE00B7SZLL34.SGD","LU0882574055.USD","LU1839511570.USD","LU0965508806.USD","LU0234570918.USD","BK4583","BK4585","IBB","IE00B3T34201.USD","LU1066051498.USD","MGNX","LU1066053197.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658494587","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2658494587","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658494587?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:36","pubTimestamp":1786480560,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 2.04% to $135.77 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.32% to 7,728.20 and Dow Jones Industrial Average  falling 0.34% to 53,791.85.Gilead Sciences Inc. closed 13.68% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  fell 0.77% to $259.80, Pfizer Inc.  fell 1.59% to $26.62, and Abbott Laboratories  rose 1.01% to $109.72.Trading volume  remained 2.9 million below its 50-day average volume of 8.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 11, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU0823416689.USD","GILD","BIB","LU0109394709.USD","IE00BSNM7G36.USD","LU1037948541.HKD","BK4583","LU1674673428.USD","LU1934455863.HKD","IE00B19Z3B42.SGD","BK4585","IBBQ","MEDI","BK4588","SG9999015978.USD","LU0320765992.SGD","LU0861579265.USD","LU0965508806.USD","IE0002270589.USD","LU0882574055.USD","LU1066053197.SGD","LU0965509101.SGD","LU1057294990.SGD","LU2112291526.USD","LU1430594728.SGD","LU0889565916.HKD","BK4566","IE00B3T34201.USD","SG9999015952.SGD","LU1066051498.USD","LU0289739699.SGD","LU2324357040.USD","SG9999015945.SGD","LU0234570918.USD","LU1934455194.USD","LU0965509010.AUD","LU2089984988.USD","LU0058720904.USD","BK4139","LU1674673691.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","BK4568","BK4532","IE00BZ1G4Q59.USD","BK4550","LU1037948897.HKD","BBH","LU1571399168.USD","LU1585245621.USD","LU0965509283.SGD","LU1934455277.USD","IBB","LU2087621335.USD","LU0122379950.USD","BMED","BK4578","TMED","LU2468319806.SGD","TBXU","LU1778281490.HKD","LU1061106388.HKD","LU0114720955.EUR","LU1839511570.USD","SG9999015986.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658594383","title":"MacroGenics Raih Pembayaran USD 10 Juta Usai Gilead Ambil Lisensi Program Bispesifik Praklinis","url":"https://stock-news.laohu8.com/highlight/detail?id=2658594383","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658594383?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:11","pubTimestamp":1786479087,"startTime":"0","endTime":"0","summary":"MacroGenics raih pembayaran USD 10 juta usai Gilead ambil lisensi program bispesifik praklinisMacroGenics mengantongi pembayaran USD 10 juta usai Gilead mengeksekusi opsi lisensi eksklusif program bis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL6BF7yf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","LU0058720904.USD","LU2089984988.USD","LU1934455863.HKD","TMED","BK4112","BK4583","IE00BGHQF748.EUR","LU2112291526.USD","LU1934455277.USD","BCDF","LU0122379950.USD","BK4568","IE0002270589.USD","BBH","IE00B3T34201.USD","IE00BN0W2V16.EUR","LU0314104364.USD","LU0320765992.SGD","BIB","SG9999015978.USD","LU2468319806.SGD","LU0965509283.SGD","BK4588","IE00B19Z3B42.SGD","LU0889565916.HKD","NDAQ","SG9999014021.USD","LU2210150020.SGD","BK4139","IE00BZ1G4Q59.USD","IBB","IE00BKPKM429.USD","MEDI","BK4532","LU1934455194.USD","LU1674673428.USD","LU0882574055.USD","IBBQ","LU1061106388.HKD","SG9999014005.SGD","BMED","MGNX","IE00BKVL7J92.USD","BK4566","TBXU","GILD","LU0861579265.USD","LU1066051498.USD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948444","title":"MacroGenics - Remains Eligible to Receive up to Approximately $1.6 Bln in Additional Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948444","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948444?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:06","pubTimestamp":1786478768,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN4481HI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","BK4550","LU0965509010.AUD","LU1839511570.USD","LU1037948541.HKD","IE00BKVL7J92.USD","LU0234570918.USD","LU0965509101.SGD","LU1430594728.SGD","IE00BZ1G4Q59.USD","BMED","LU0965509283.SGD","LU1778281490.HKD","SG9999015952.SGD","LU0109394709.USD","LU1674673428.USD","LU1585245621.USD","LU1571399168.USD","IE00B19Z3581.USD","LU0058720904.USD","MEDI","LU0965508806.USD","LU0889565916.HKD","BK4583","SG9999015945.SGD","LU1066051498.USD","MGNX","GILD","LU2468319806.SGD","LU1934455863.HKD","BK4532","SG9999015978.USD","SG9999015986.USD","BK4568","LU0882574055.USD","LU1674673691.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","BK4578","LU0289739699.SGD","BK4585","LU2112291526.USD","BIB","IBBQ","IE00B3T34201.USD","LU1934455277.USD","TBXU","TMED","BBH","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658147129","title":"Amgen’s AMG 355 Trial Completion: What This Early Cancer Study Means for AMGN Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658147129","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658147129?lang=en_us&edition=fundamental","pubTime":"2026-08-12 00:30","pubTimestamp":1786465821,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. has completed a first-in-human trial of AMG 355 in advanced solid...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-amg-355-trial-completion-what-this-early-cancer-study-means-for-amgn-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-amg-355-trial-completion-what-this-early-cancer-study-means-for-amgn-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIB","LU2089984988.USD","LU2468319806.SGD","LU0320765992.SGD","LU1023059063.AUD","TBXU","LU2242646821.SGD","LU1057294990.SGD","IBB","IE00B64PRP62.GBP","PBE","BK4581","SG9999001440.SGD","LU2112291526.USD","BK4566","AMG","BK4599","IE0002141913.USD","ISBC","IE00B2B36J28.USD","LU0109394709.USD","LU1061106388.HKD","BK4534","IE00BFTCPJ56.SGD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","AMGN","BK4135","LU0058720904.USD","BK4585","IBBQ","BK4211","IE00B4R5TH58.HKD","BK4588","IE00B3QW5Z07.USD","BK4533","BBH","LU0889565916.HKD","IE0009355771.USD","BK4505","LU0289739699.SGD","LU1983299246.USD","PJP","IE00BGHQF748.EUR","LU1571399168.USD","LU2242652126.USD","BK4139","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}